Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapy.
Journal Information
Full Title: Theranostics
Abbreviation: Theranostics
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data availability statement all rna-seq raw data and processed read counts have been submitted to gene expression omnibus (gse243980) metabolomics data of bacteria have been deposited in the embl-ebi under accession code mtbls8667. data availability statement all rna-seq raw data and processed read counts have been submitted to gene expression omnibus (gse243980"
"Competing Interests: The authors have declared that no competing interest exists."
"This work was supported by the National Natural Science Foundation of China (82273831, 82001753, 82311540161, 82171469, and 81960556), Hunan Natural Science Foundation (2023JJ20022), and Fundamental Research Funds for the Central Universities, China (541109030048)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025